Browsing: Merck
Merck KGaA press release (OTCPK:MKGAF): FY Non-GAAP EPS of €8.63. Revenue of €21.16B (+0.8% Y/Y) (organically: +2.0%). EBITDA pre rose…
Marko Georgiev/Getty Images NewsMerck (NYSE:MRK) shares were on track to snap six straight sessions of gains on Wednesday, as the…
Sundry PhotographyMerck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting…
Grandbrothers ImmunityBio (NASDAQ:IBRX) announced Wednesday it has received U.S. regulatory clearance to bring an alternative BCG treatment source to facilitate…
Erik S. Lesser/Getty Images NewsMerck (NYSE:MRK) announced Tuesday that the European Commission approved its anti-cancer agent Welireg (belzutifan) as a…
A weekly summary of insider trading highlighting a few notable buying and selling by investors, directors and executives. The trades…
designer491/iStock via Getty ImagesUpdate 2:15pm: Adds Merck KGaA confirmation. SpringWorks Therapeutics (NASDAQ:SWTX) soared ~40% after a report that Merck KGaA…
FloortjeMajor stock indexes closed lower on Friday, after the week saw a flurry of corporate earnings reports from major tech…
Sundry PhotographyThe FDA has accepted Merck’s (NYSE:MRK) supplemental New Drug Application with priority review for its drug Welireg, also known…
Erik S. Lesser/Getty Images NewsMerck (NYSE:MRK) is preparing to launch a subcutaneously delivered formulation of their blockbuster cancer medication Keytruda…